New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
NFH.WS was delisted on the 26th of January, 2022.
13 hedge funds and large institutions have $8.95M invested in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
66% more capital invested
Capital invested by funds: $5.41M → $8.95M (+$3.55M)
18% more funds holding
Funds holding: 11 → 13 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$128K |
| 2 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$14.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$7K |
NFH.WS Hedge Fund Activity: Q2 2021 in Review
13 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) for Q2 2021, worth a combined $8.95M — up 66% from $5.41M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NFH.WS positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $14. The largest seller was Warberg Asset Management, exiting entirely with an estimated $128K sold.
- 13 institutional investors held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) as of Q2 2021, up from 11 in Q1 2021.
- Funds reported $8.95M of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a stock for Q2 2021, up 66% quarter-over-quarter.
- 3 funds opened new New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a positions in Q2 2021 and 1 closed out, a net change of +2 holders.
- The largest New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a buyer in Q2 2021 was UBS Group, an estimated $14 added.
- The largest New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a seller in Q2 2021 was Warberg Asset Management, an estimated $128K sold.
Based on aggregated 13F filings for Q2 2021.